Innovative Glucagon-like Peptide 1 Receptor Agonists: Exploring the Therapeutic Potential of Specific Modified Monomer, Dimer, and Tetramer in Type 2 Diabetes Treatment

发表于 2026-7-15 10:14:16

期刊：Bioconjugate Chemistry

文献作者：Yan Du; Tao Liu; Hua-Lin Li; Qun Luo; Xiao-Yuan Guo; Jian-Yun Wang; Xin-Rui Wang; Ya-Man Zhou; Ya-Wen Pan; Li-Cheng Yu; Hong-Mei Tan; Ke-Sheng Hu; Song-Shan Tang

出版日期：2025-8-20

DOI号：10.1021/acs.bioconjchem.5c00261

下载链接：https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.5c00261

文献链接：https://doi.org/10.1021/acs.bioconjchem.5c00261

当前文献来源于 American Chemical Society (ACS)。

备注信息：

发表于 2026-7-15 10:14:17

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ACS] Innovative Glucagon-like Peptide 1 Receptor Agonists: Exploring the Therapeutic Potential of Specific Modified Monomer, Dimer, and Tetramer in Type 2 Diabetes Treatment

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ACS] Innovative Glucagon-like Peptide 1 Receptor Agonists: Exploring the Therapeutic Potential of Specific Modified Monomer, Dimer, and Tetramer in Type 2 Diabetes Treatment 一键复制